Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Liabilities: 2018-2024

Historic Total Liabilities for Neurogene (NGNE) over the last 4 years, with Dec 2024 value amounting to $25.4 million.

  • Neurogene's Total Liabilities fell 16.53% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year decrease of 16.53%. This contributed to the annual value of $25.4 million for FY2024, which is 30.63% down from last year.
  • As of FY2024, Neurogene's Total Liabilities stood at $25.4 million, which was down 30.63% from $36.5 million recorded in FY2023.
  • Neurogene's 5-year Total Liabilities high stood at $36.5 million for FY2023, and its period low was $25.4 million during FY2024.
  • Moreover, its 2-year median value for Total Liabilities was $31.0 million (2023), whereas its average is $31.0 million.
  • Data for Neurogene's Total Liabilities shows a maximum YoY plummeted of 30.63% (in 2024) over the last 5 years.
  • Neurogene's Total Liabilities (Yearly) stood at $36.5 million in 2023, then tumbled by 30.63% to $25.4 million in 2024.